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MULTILEVEL JOINT ANALYSIS OF LONGITUDINAL AND BINARY
OUTCOMES
Seo Yeon Hong, PhD
University of Pittsburgh, 2012
Joint modeling has become a topic of great interest in recent years. The models are simulta-
neously analyzed using a shared random effect that is common across the two components.
While these methods are useful when time-to-event data are available, there are many cases
where the outcome of interest is binary and a logistic regression model is used. We propose
the use of a joint model with a logistic regression model being used for the binary outcome
and a hierarchical mixed effects model being used for the longitudinal outcome. We link
the two sub-models using both subject and cluster level random effects and compare it with
models using only one level of random effects. We use the Gaussian quadrature technique im-
plemented in the software package aML (Multiprocess Multilevel Modeling software). Sim-
ulation studies are presented to illustrate the properties of the proposed model. We also
applied our model to the repeated measures of mid-arm muscle circumference (MAMC)
and mortality rate for patients within 75 units from 15 centers from a randomized study
of hemodialysis (HEMO) and found that the model performs well. We further extend this
work by developing methods that can be used to calculate individualized predictions based
on our proposed joint model. We use the Bayesian approach to obtain these predictions and
implement the method in the software package WinBUGS. The proposed method provides
a mechanism for understanding the relationship between a longitudinal measure and a given
binary outcome. Thus, it can be used to address several types of public health problems.
First, it can be used to understand how changes in a biomarker or other longitudinal measure
are related to changes in status of a subject. Second, it can be used to predict the outcome
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of a subject based on the trajectory of the longitudinal outcome providing information that
can be used in a personalized medicine setting. This allows researchers to identify potentially
harmful patterns and intervene at an earlier stage.
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1.0 LITERATURE REVIEW
1.1 JOINT MODEL
Joint modeling has become a topic of great interest in recent years. The focus has been
primarily on models that include a longitudinal and a survival component. In the past,
the repeated measures and failure outcomes are treated separately. However, when the two
outcomes are related, the separate models may be both inappropriate and uninformative.
Joint models have several advantages. They can incorporate (i) time-varying variables, (ii)
informative dropout and (iii) censored longitudinal covariates.
The most common approach to the construction of a joint model is the use of shared
random effects. The models are simultaneously analyzed using a shared random effect that is
common across the two components. The random effects, bi, which usually follow a normal
distribution, are used to link the repeated measures, yi, and the event time of survival
outcome, di. The joint likelihood is as follows [1]:
L =
n∏
i=1
∫
f(yi, di|bi)f(bi)dbi
=
n∏
i=1
∫
f(yi|bi)f(di|bi)f(bi)dbi.
where f(bi) has a certain distribution.
We will first review the joint model for a longitudinal outcome and a survival outcome.
Then, we will summarize the joint modeling of a longitudinal and a binary outcome. Finally,
we will assess the joint model in multilevel data.
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1.1.1 Joint Model of Longitudinal and Survival Data
Tsiatis et al. [2] used a two-stage approach where the longitudinal process and the Cox
proportional hazards model is incorporated. In the first stage, the linear mixed effects model
is used and then in the second stage, the empirical Bayes estimates replaced the covariates
of the Cox model. They also applied the method to survival and CD4 counts in patients
with AIDS.
Schluchter [3] discussed several methods for modeling informatively censored longitudinal
data. When informative censoring occurs, it causes problems such as bias in the standard
likelihood-based analyses. He pointed out that the Expectation-Maximization (EM) algo-
rithm has several advantages when applied to this problem, namely that it allows for unbal-
anced data and unequally spaced time intervals. The EM algorithm (Dempster, Laird and
Rubin [4] ) has been a popular method in the joint random effects model framework. The
EM algorithm is an iterative optimization method used to estimate some unknown parame-
ters. More generally, the EM algorithm can be described as follows for a general likelihood
function;
l(θ) = logp(x|θ) = log
∑
z
p(x, z|θ)
= log
∑
z
q(z|x, θ)p(x, z|θ)
q(z|x, θ)
≥
∑
x
q(z|x, θ)logp(x, z|θ)
q(z|x, θ) ≡ F (q, θ),
where X denotes the observed variables, Z denotes the unobserved latent variables and θ
is an unknown parameter vector. Note that logp(x, z|θ) is a complete log-likelihood and
q(z|x, θ) is an arbitrary density over Z. In the E-step, the random coefficients are estimated
using the conditional expectation of the log-likelihood given the observed data, that is,
E-step: q(t+1) = argmax
q
F (q, θ(t)).
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Then, in the M-step, the expected log-likelihood is maximized using the estimated random
effects yielding
M-step: θ(t+1) = argmax
θ
F (q(t+1), θ).
DeGruttola and Tu [5] applied the EM algorithm to a joint model of the progression of CD4-
lymphocyte count and survival time using random effects. They assumed that the joint
distribution of the covariate process and survival times were multivariate normal. Wulfshon
and Tsiatis [6] relaxed some of the assumptions placed on prior methods. They assumed that
the individual’s random effects need not be normally distributed at every time point since
the risk set changes at each failure time. Henderson et al. [7] proposed that the two models
are linked by a common latent stochastic process. The researchers used a latent bivariate
Gaussian process W (t) = {W1(t),W2(t)} and assumed that the repeated measurement and
the failure time process were conditionally independent given W (t) and the covariates. The
association of the two outcomes was created through the cross-correlation between W1(t) and
W2(t). Therefore, the joint distribution of both outcomes for the ith subject is assumed to
be an unobserved or latent zero-mean bivariate Gaussian process, Wi(t) = {W1i(t),W2i(t)}.
The sub-model for the repeated measurements part is as follows;
Yij = X1i(t)
′β1 +W1i(tij) + ij, (1.1)
where X1i(t) are possiblely time-varying covariates and β1 are the corresponding coefficients
associated with the repeated measures. The sequence of mutually independent measurements
errors, ij is assumed to be N(0, σ
2
 ). The other sub-model is the semi-parametric model for
the event intensity process at time t, and is given by
λi(t) = Hi(t)λ0(t)exp{X2i(t)′β2 +W2i(t)}, (1.2)
with Hi(t) being the zero-one process and λ0(t) being the unspecified form of the baseline
hazard. Estimation for the models described in (1.1) and (1.2) is based on an extension of
the EM algorithm. Lin et al. [8] introduced a joint model comprised of multiple longitudinal
outcome variables and a survival outcome. The model incorporated the correlations among
longitudinal co-variables and used a one-step-late EM algorithm.
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Song et al. [9] also tested the sensitivity of violation of the normality assumption in a
joint model with a longitudinal and a survival outcome based on the EM algorithm. They
relaxed the assumption of a smooth density and found that the results were remarkably
robust and consistent to the assumption of normality. For the same joint model, Hsieh et al.
[10] confirmed that the joint likelihood with the normality assumption of random effects is
robust and efficient as long as the longitudinal outcome does not carry large measurement
errors.
The Markov chain Monte Carlo (MCMC) methods are another widely used algorithm in
the joint model setting. In Bayesian inference, the unknown random effects are estimated
based on the posterior distribution. The previous sample values are used to randomly gen-
erate the next set of sample values until the Markov chain reaches a stationary distribution.
Faucett and Thomas [11] simultaneously analyzed repeated measurements as a prediction of
disease risk. They used the Markov chain Monte Carlo technique of Gibbs sampling to esti-
mate the unknown parameters. Gibbs sampling is a special case of the Metropolis-Hastings
algorithm. Suppose that x = (x1, x2, . . . , xk) is from a joint distribution p(x1, x2, . . . , xk).
The samples are updated as follows:
X
(t+1)
1 ∼ p(x1|x(t)2 , x(t)3 , . . . , x(t)k )
X
(t+1)
2 ∼ p(x2|x(t+1)1 , x(t)3 , . . . , x(t)k )
X
(t+1)
3 ∼ p(x3|x(t+1)1 , x(t+1)2 , x(t)4 . . . )
...
...
X
(t+1)
k ∼ p(xk|x(t+1)1 , x(t+1)2 , . . . , x(t+1)k−1 ).
From the updated samples, the most recent values are used. Their method reduced bias
in the parameter estimates due to covariate measurement error and informative censoring.
Later, Xu and Zeger [12] generalized the Markov chain Monte Carlo technique using a latent
variable. Guo and Carlin [13] developed the method of Henderson et al. into a fully Bayesian
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version using the Markov chain Monte Carlo technique. The researchers applied the method
to the CD4 counts and time to death simultaneously via a latent bivariate Gaussian process.
Hogan and Laird [14] focused on incomplete data in the longitudinal measurements in
the joint modeling setting. They used the missing mechanisms described in Little and Rubin
[15], and discussed below. If missingness does not depend on the data Y, then it is defined
as missing completely at random (MCAR). In this case
f(M |Y, φ) = f(M |φ) for all Y, φ,
where Y is the complete data, M is missing-data indicator matrix and φ denotes the unknown
parameters. If missingness depends only on observed components, Yobs, then the missing-
data mechanism is called missing at random (MAR) and
f(M |Y, φ) = f(M |Yobs, φ) for all Ymis, φ,
where Yobs denotes the observed components and Ymis denotes the missing components. If
missingness depends on the missing values in the data Y, then it is called not missing at
random (NMAR). They also discussed selection and mixture models for the evaluation of
missing values in both longitudinal and survival outcomes.
Tsiatis and Davidian( [16], [17] ) generalized the joint model by placing no assumptions
on the distribution of the random effects. Prior to this work, most methods assumed that the
random effects followed a normal distribution. They relaxed the assumptions of normality
of the random effects and their semiparametric approach may cause a loss of efficiency
relative to the models where the parametric specification for the random effects is made.
They used the conditional score (CS) approach proposed by Stefanski and Carroll [18].
The conditional score is obtained by conditioning on certain sufficient statistics when the
explanatory variables are fixed constants. Later, Song et al. [19] extended this approach to
include multiple, possibly correlated, time-dependent covariates using the conditional score
method.
Proc NLMIXED [20] is an another convenient tool for estimation in the joint modeling
setting. Vonesh et al. [21] proposed a joint model comprised of parametric or semiparametric
survival models for the survival component and the generalized linear or non-linear mixed-
effects models for the longitudinal component. This allows flexibility in the specification of
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the distribution of the event time and the association of the longitudinal outcome. They
used the Laplace approximation implemented in Proc NLMIXED in SAS to obtain estimates
from the model. Liu [22] considered a joint model when the values of the repeated measures
contain a large number of zero values and right-skewed positive values. They applied the
method to the longitudinal monthly medical costs of chronic heart-failure patients using the
Gaussian quadrature techniques implemented in SAS Proc NLMIXED [23].
We have discussed several estimation methods for the joint model of longitudinal and
survival outcomes. Due to the unknown random effects, the Expectation-Maximization
(EM) and Markov chain Monte Carlo (MCMC) algorithms have been the popular methods
and extended in many ways. Also, some papers focused on incomplete data in longitudinal
measurements. The conditional score (CS) approach was another method used to relax
the normality assumption of random effects. Recently, Proc NLMIXED in SAS has been
conveniently utilized, since it can easily accommodate a user-specified likelihood. While
these methods are useful when time-to-event data are available, there are many cases where
the outcome of interest is binary and a logistic regression model is used. We will discuss
some papers where a binary outcome was used in place of a survival outcome.
1.1.2 Joint Model of Longitudinal and Binary Data
Wang et al. [24] considered a joint model using a naive estimator. They used a regression cal-
ibration (RC) estimator, where repeated measurements were assumed to be linear. However,
when the measurements were nonlinear, the RC model produced a biased estimator. They
used the refined RC (RR) estimator in logistic regression to generate an unbiased estimate.
Li et al. [25] introduced the sufficiency score (SS) and the conditional score (CS), which
generalized the linear model with no distributional assumptions on the random effects and
consistent inference even when the distribution was misspecified. Later, Li et al. [26] devel-
oped the generalized sufficiency score (GSS) and the generalized conditional score (GCS),
which have no distributional nor covariance structural assumptions placed on the covariate
random effects. These approaches are more flexible and are applicable to the multivariate
longitudinal covariate processes.
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Horrocks et al. [27] considered the prediction of pregnancy based on longitudinal measure-
ments of adhesiveness of certain blood lymphocytes. They used the joint model developed by
Wang et al. [24] and used a Bayesian approach to estimate the parameters as implemented
in WinBUGS. Wannemuehler et al. [28] explored the joint model of longitudinal and logistic
health outcomes in left- and interval-censored data. They compared the joint model with a
two-stage approach, and the joint modeling approach implemented in SAS Proc NLMIXED
performed better with little bias and near-nominal confidence interval coverage.
In summary, the sufficiency score (SS) and the conditional score (CS) methods were used
to relax the distributional assumptions on the random effects. Also, Bayesian methods and
the likelihood-based approach were discussed in the joint modeling of a longitudinal and a
binary outcome.
1.1.3 Joint Model with Multilevel Data
Hierarchical or clustered structures are presnet in many biomedical studies. A common
example is in longitudinal studies where an individual’s repeated measures are correlated with
each other. Individuals may be further nested within geographical areas or institutions such
as schools or hospitals. In this situation, there are clustering effects due to the correlation
between the same levels nested within the higher levels. As a result of this clustering, there
are different random effects between levels, so we can use mixed model to account for these
random effects.
Ratcliffe et al. [29] developed a joint model for the longitudinal and survival outcome
in multilevel data. They linked the two submodels with cluster-level random effects and
applied the EM algorithm to estimate the parameters. In the presence of clustered data, the
cluster-level linkage performed better than a subject-level link.
Liu et al. [30] linked the joint model of a longitudinal and a survival outcome using both
cluster level and subject level random effects. They used the Gaussian quadrature technique
implemented in aML (Multiprocess Multilevel Modeling software [31] ). The researchers
showed that failure to satisfy the assumptions placed on the dependence structure between
the outcomes can cause serious biases.
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The joint model of longitudinal and binary outcomes in multilevel data is still under
development. The focus of this paper is on the setting where we only have information
about the events (dead or alive), but not the failure time in the presence of the clustering
effect. This model is applicable in a setting where the data are hierarchically structured, such
as, hospitals at level 1, patients at level 2, and longitudinal measurements at level 3. In other
words, when the subjects are clustered within higher levels, the random effects are different
between their levels. This work focuses on the setting where the longitudinal outcome is
subject to multiple hierarchical levels and the second outcome is binary. We propose the
use of a joint model with a logistic regression model being used for the binary outcome and
a hierarchical mixed effects model being used for the longitudinal outcome. Here, we link
the two sub-models using both subject and cluster level random effects and compare it with
models using only one level of random effects. We present simulation results that compare
the results of a single level random effect to the multi-level random effects. Then we apply
this model to the motivating example of the HEMO data [32].
Another major issue in joint modeling is the estimation of predicted values for each of
the observations in the data set. While there has been some research related to prediction
for the joint model of longitudinal and survival outcomes, there has been little work for
joint model of longitudinal and binary outcomes. To address this issue we obtain individual
predictions for our proposed joint model. Through fitting our model in WinBUGS, which is
based on the Bayesian method using a Markov chain Monte Carlo (MCMC), we will obtain
estimates of the individual predicted probability. Then, we can assess the performance of
the longitudinal measures in the prediction of mortality.
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2.0 MULTILEVEL JOINT ANALYSIS OF LONGITUDINAL AND BINARY
OUTCOME
2.1 INTRODUCTION
Joint modeling has become a topic of great interest in recent years, seeing extensions to
methodology for jointly modeling two different outcomes, extensions to accommodate in-
formative censoring and methods for incorporating censored longitudinal covariates into a
survival model. These methods address the need to link longitudinal information to other
types of models and provide for improved estimates. This is in contrast to traditional meth-
ods where each component is modeled separately or where the longitudinal component is
included as a time-varying covariate in a survival model, providing potentially biased re-
sults. While joint models offer the advantage of allowing for the joint assessment of two
outcomes and the reduction in bias in estimates, the models can be difficult to fit and need
extra care in interpretation.
The focus of work in the area of joint modeling has primarily been on the development
of models that include a longitudinal and a survival component in a single model. Re-
search in this area has centered on several different approaches; the use of the expectation-
maximization (EM) and Markov chain Monte Carlo (MCMC) algorithms to obtain estimates
for the joint model and the use of the full likelihood. The EM algorithm has been used by
many researchers. DeGruttola and Tu [5] assumed that the joint distribution of the covari-
ate process and survival times were multivariate normal. Wulfshon and Tsiatis [6] assumed
that the individual’s random effects need not be normally distributed all the time when the
individuals are at risk at each event time and thus removed from observation. Henderson et
al. [7] proposed that the two models are linked by a common latent stochastic process. Lin
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et al. [8] introduced multiple longitudinal variables and the survival outcome. The model
incorporated the correlations among longitudinal co-variables. Song et al. [9] relaxed the
assumption with a smooth density and found out the results were remarkably robust and
consistent to the assumption of normality. Hsieh et al. [10] confirmed that the joint like-
lihood with normality assumption of random effects is robust and efficient as long as the
longitudinal outcome does not carry large measurement errors.
Several researchers applied the MCMC approach to joint modeling as well. Faucett and
Thomas [11] used the Markov chain Monte Carlo technique of Gibbs sampling to estimate
unknown parameters. Xu and Zeger [12] generalized the Markov chain Monte Carlo technique
using a latent variable. Guo and Carlin [13] developed the method of Henderson into a fully
Bayesian version using the Markov chain Monte Carlo technique.
PROC NLMIXED in SAS [20] has been another widely used piece of statistical software
for joint modeling using the likelihood approach. Vonesh et al. [21] proposed a joint model
including parametric and semiparametric survival models and generalized linear or non-
linear mixed-effects models which allow for flexibility in the specification of the distribution
of the event time for the survival component of the joint model. They used the Laplace
approximation implemented in PROC NLMIXED in SAS for fitting this model. Liu [22]
also used PROC NLMIXED for the case where the repeated measures outcome contains a
large number of zero values and right-skewed positive values. Tsiatis and Davidian ([16], [17])
generalized the joint model by developing a model where there are no assumptions placed
on the distribution of the random effects. They used the conditional score (CS) approach
proposed by Stefanski and Carroll [18]. This was later extended to the setting where there
are multiple, possibly correlated, time-dependent covariates (Song et al. [19]).
The motivation for this work arose from several practical applications where one of the
outcomes of interest was a binary outcome, rather than a survival outcome. One example
arose out of a study of intensive care units looking at the relationship between in-hospital
mortality and daily sunlight exposure while in the intensive care unit. The second example
came out of a clinical trial of dialysis approaches and mortality. In these setting, there was
interest in examining the relationship between longitudinal measures of mid-arm muscle cir-
cumference (MAMC) and mortality. While there has been some development of joint models
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for binary and longitudinal outcomes, these modeling techniques are not as well developed
as those that are available for a joint model including survival and a longitudinal outcome
and there have been no models developed for hierarchically structured data. Horrocks [27]
used a Bayesian approach for the prediction of pregnancy and other authors have used the
sufficiency score (SS) and the conditional score (CS) to develop joint models with a binary
and longitudinal outcome with no assumptions placed on the random effects ([25], [26]). The
incorporation of multilevel data into the joint model has not been as widely studied. Ratcliffe
et al. [29] developed a joint model for a longitudinal and survival outcome in multilevel data
linking the two submodels with cluster-level random effects. The EM algorithm was then
used to obtain parameter estimates from this joint model. They then showed that cluster-
level linkage performed better than a subject-level linkage in the presence of clustered data.
Liu et al. [30] linked the joint model composed of a longitudinal and survival outcome using
both cluster level and subject level random effects. To implement this method, they used
the Gaussian quadrature technique implemented in aML (Multiprocess Multilevel Modeling
software [31]). They also showed that the model is sensitive to the assumptions on the de-
pendence structure between the outcomes, resulting in serious bias when these assumptions
are violated.
The focus of this work is on the development of a joint model in the multilevel data setting
where the outcomes include a binary and a longitudinal outcome. This model is applicable in
setting where data are hierarchically structured, such as, hospitals at level 1, patients at level
2, and longitudinal measurements at level 3. In other words, when the subjects are clustered
within higher levels, the random effects are different between their levels. This work focuses
on the setting where the longitudinal outcome is subject to multiple hierarchical levels and
the second outcome is binary. We propose the use of a joint model with a logistic regression
model being used for the binary outcome and a hierarchical mixed effects model being used
for the longitudinal outcome. Here, we link the two sub-models using both subject and
cluster level random effects and compare it with models using only one level random effects.
We showed the simulation results which were compared with the results of one level random
effects. Then we applied this model to the motivating example of the HEMO data [32].
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2.2 METHODS
Let Yijk denote the k-th repeated measure for the j-th subject within i-th cluster (i =
1, 2, ..., n, j = 1, 2, ..., ni, and k = 1, 2, ...,mij). Let pij denote the probability of response
for the j-th subject of a binary zero-one outcome variable, Xij. Let Zijk and Wij denote
the covariate vectors of fixed effects for the longitudinal outcome model and the logistic
regression model, respectively. We assume that the missing mechanism is missing at random
(MAR). Under this assumption, we keep all of the observations in the sample whether the
observations are missing or not. The missing data simply do not contribute to the estimation.
As shown in (2.2) below, the repeated measures k are indexed from 1 to mij. In this model,
ai and bij denote the random effects at the cluster and subject levels, respectively. They are
assumed to be independent and identically distributed according to a normal distribution
with mean 0 and corresponding variances, e.g. σ2a and σ
2
b .
We define the joint model as
yijk = Z
T
ijkβ + ai + bij + eijk
logit(pij) = Wijα + γ1ai + γ2bij,
(2.1)
where β and α are unknown vectors of parameters. In this model γ1 and γ2 represent the
association between the two models at each cluster and subject level. The error term, eijk is
assumed to be N(0, σ2e) and independent of (ai, bij, Xij). Let Oij denote the observed data
for the i-th subject within the j-th cluster, then the likelihood is as follows:
L =
n∏
i=1
Li =
n∏
i=1
∫ ni∏
j=1
Lijφ(ai)dai (2.2)
where
Lij =
∫
L(Oij|ai, bij)dbij
12
=∫ mij∏
k=1
φ(eijk)
[
ni∏
j=1
p
xij
ij (1− pij)(1−xij)
]
φ(bij)dbij.
Note that
eijk = yijk − ZTijkβ − ai − bij,
and that φ(ai) represents a normal density function with mean 0 and variance σ
2
a. Likewise,
φ(bij) is the normal density function with mean 0 and variance σ
2
b . Here, xij denotes the
realization of Xij.
We also considered the two reduced models discussed by Liu et al. [30]. The first model
we consider, ‘reduced model A’, restricts the number of random effects related to the binary
outcome by including only the cluster-level random effect, ai, in the model. This results in
a model where γ2 in equation (2.1) is set equal to zero and is written as
yijk = Z
T
ijkβ + ai + bij + eijk
logit(pij) = Wijα + γ1ai.
(2.3)
The other model we consider, ‘reduced model B’, restricts the number of random effects
related to the binary outcome by including only the subject-level random effect, bij, in the
model. This results in a model where γ1 in equation (2.1) is set equal to zero and is written
as
yijk = Z
T
ijkβ + ai + bij + eijk
logit(pij) = Wijα + γ2bij.
(2.4)
The likelihoods of the reduced models are different in terms of the pij when compared
to our model, which includes both subject and cluster level random effects. Note that the
likelihood equations presented in (2.2) will include a single integration.
The integration of the random effects in (2.2) requires the use of special software. Proc
NLMIXED in SAS is a convenient tool for the fitting of joint models. However, our data is
multilevel data and Proc NLMIXED in SAS can not handle clustered level random effects.
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We used the aML software to implement the joint model using Gaussian quadrature tech-
niques. This software is specific for the estimation of multilevel and multiprocess models. It
uses a numerical integration algorithm based on Gaussian quadrature techniques. We used
five quadrature points for the simulation study and it was enough for this purpose. Also,
we used 50 quadrature points for our application data to get more accurate results. Huber-
corrected standard error estimates were used for the covariance matrix of the parameter
estimates which is robust to heteroscedasticity.
2.3 SIMULATION STUDY
We conducted simulation studies to identify the sensitivity of the estimates when the as-
sumptions of the dependence structure were violated. We compared our full model with two
reduced models which included only one of the random effect terms. The ‘reduced model A’
was only linked via the cluster-level random effect and ‘reduced model B’ was only linked
via the subject-level random effect. We generated data for the simulation study following
that outlined in Liu et al. [30]. For all simulations we simulated data on 500 subjects with
a cluster size of 50, so that there were 10 subjects within each of the clusters. The results
presented are based on 600 simulated samples for each scenario. The model below was used
for generating data:
yijk = β0 + β1Zij + β2time+ ai + bij + eijk
logit(pij) = α0 + α1Zij + γ1ai + γ2bij.
Let yijk represent the repeated measurement at the integer time k, with k ranging from
1 to 5. We generated the subject-level covariate, Zij, from a binary distribution with prob-
ability 0.5. Coefficent parameters were β = (β0, β1, β2)
T = (−1,−.5,−.2)T . The random
intercepts ai and bij were also included in the model. We assumed ai
iid∼ N(0, σ2a) with σ2a = 1
and bij
iid∼ N(0, σ2b ) with σ2b = 1. Since the repeated measures from a subject j share the
common random effects bij and the subjects from a cluster share the common random effects
ai, the correlation is induced from the random effects. Here, the covariance structure is
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compound symmetry where the variance at all time points is the same and the correlation
between any two distinct measurements is the same. The covariance structure is as follows:
COV (yijk) =
σa2 + σb2 + σe2

1
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
1
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
1
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
1
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
σa2+σb2
σa2+σb2+σe2
1

The error term was eijk
iid∼ N(0, σ2e) with σ2e = 1. The logistic regression included an
intercept α0 and the subject-level covariate Zij with coeficient α = (α0, α1)
T = (1.5,−1)T .
Also, the random effects ai, at the cluster level, and bij, at the subject level, were included
in the model. In case I, we assumed that the coefficient parameters γ = (γ1, γ2)
T = (1, 1)T .
Non-adaptive Gaussian quadrature with 5 quadrature points was implemented in aML.
Table 1 presents the simulation results. As expected, the estimates of the proposed model
had very small biases and the coverage probability showed that the model performed much
better than the other two reduced models. The reduced model A was where the model was
linked only via the cluster-level random effect. Likewise, the reduced model B was set to
be linked only via the subject-level random effects. The reduced model A showed a lower
coverage probability percent in the parameters α0, α1 and γ1 than our model. Also, the
estimates were biased for the parameters α0, α1 and σa in the reduced model B.
In case II, we assumed that the coefficient parameters γ = (γ1, γ2)
T = (1, 0)T and other
parameters remained the same in case I. In this case, the reduced model A was the true
model. The results can be seen in Table 2. The estimates of the proposed model are still
unbiased and the coverage probability percent is reasonable. However, reduced model B
showed lower coverage probability for α0, α1 and γ2.
In case III, we also generated the data with γ = (γ1, γ2)
T = (0, 1)T , where the reduced
model B was the true model. The proposed model still showed unbiased estimates and
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reasonable coverage probability. In the reduced model A, α0, α1 and γ1 were poorly estimated
with low coverage probability. The results are presented in Table 3.
16
Table 1: Simulation Results for case I : γ = (γ1, γ2)
T = (1, 1)T
Our model Reduced model A Reduced model B
Parameter Est SE CP Percent Est SE CP Percent Est SE CP Percent
β0 = −1 -0.997 0.161 94.33 -0.997 0.161 94.34 -0.998 0.161 94.33
β1 = −0.5 -0.503 0.101 94.83 -0.503 0.102 95.01 -0.503 0.103 94.67
β2 = 0.2 0.200 0.014 94.50 0.200 0.014 94.51 0.201 0.014 94.50
α0 = 1.5 1.563 0.252 93.50 1.303 0.206 80.17 1.288 0.209 78.33
α1 = −1 -1.040 0.261 94.17 -0.869 0.216 90.83 -0.858 0.229 89.33
γ1 = 1 1.022 0.147 93.17 0.934 0.119 85.81
γ2 = 1 1.051 0.168 93.67 0.995 0.135 94.17
σa = 1 0.982 0.108 93.50 0.986 0.107 93.99 0.815 0.101 53.33
σb = 1 0.997 0.039 94.83 0.995 0.039 94.99 1.024 0.043 91.83
σe = 1 1.000 0.016 92.50 1.000 0.016 92.50 1.000 0.016 92.50
CP is the coverage probability of the 95 percent confidence interval.
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Table 2: Simulation Results for case II : γ = (γ1, γ2)
T = (1, 0)T
Our model Reduced model A Reduced model B
Parameter Est SE CP Percent Est SE CP Percent Est SE CP Percent
β0 = −1 -0.998 0.161 94.17 -0.998 0.161 94.17 -0.997 0.161 94.33
β1 = −0.5 -0.502 0.101 95.17 -0.502 0.101 95.00 -0.503 0.101 94.67
β2 = 0.2 0.201 0.014 94.50 0.201 0.014 94.50 0.201 0.014 94.50
α0 = 1.5 1.512 0.225 93.83 1.506 0.224 93.67 1.268 0.193 73.83
α1 = −1 -1.013 0.222 95.67 -1.010 0.221 96.17 -0.855 0.201 88.67
γ1 = 1 1.014 0.147 93.00 1.010 0.145 93.00
γ2 = 0 -0.009 0.124 95.00 0.096 0.108 85.50
σa = 1 0.983 0.108 93.33 0.983 0.108 93.33 0.966 0.108 91.67
σb = 1 0.998 0.039 95.00 0.998 0.039 95.00 1.000 0.040 95.17
σe = 1 1.000 0.016 92.50 1.000 0.016 92.50 1.000 0.016 92.50
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Table 3: Simulation Results for case III : γ = (γ1, γ2)
T = (0, 1)T
Our model Reduced model A Reduced model B
Parameter Est SE CP Percent Est SE CP Percent Est SE CP Percent
β0 = −1 -1.002 0.170 94.13 -0.997 0.161 94.17 -0.998 0.161 94.17
β1 = −0.5 -0.502 0.111 93.96 -0.503 0.101 94.67 -0.502 0.101 93.83
β2 = 0.2 0.201 0.014 94.46 0.201 0.014 94.50 0.201 0.014 94.50
α0 = 1.5 1.523 0.306 93.79 1.262 0.152 64.00 1.440 0.174 92.50
α1 = −1 -1.008 0.319 94.63 -0.842 0.199 85.33 -0.955 0.226 93.00
γ1 = 0 0.026 0.617 96.31 0.082 0.103 88.33
γ2 = 1 1.030 0.208 93.29 0.976 0.135 91.83
σa = 1 0.986 0.178 93.46 0.983 0.108 93.33 0.984 0.106 93.17
σb = 1 0.998 0.073 95.13 0.998 0.039 95.00 0.998 0.039 95.33
σe = 1 1.000 0.016 93.29 1.000 0.016 92.50 1.000 0.016 92.50
We also simulated data for both random intercept and random slope effects. The model
was as follows:
yijk = β0 + β1Zij + β2time+ ai + b1ij + b2ijtime+ eijk
logit(pij) = α0 + α1Zij + γ1ai + γ2b1ij + γ3b2ij
The model was linked with the three random effects, which were the cluster-level random
intercept ai, the subject-level random intercept b1ij and the subject-level random slope b2ij.
The b2ij shows the within subject variation over time. The coefficient parameter γ3 and
the variance component σb
2
2 were set to be .5. The results for the proposed model showed
reasonable estimates. The results are shown in Table 4.
We also conducted several different simulation studies by changing the sample size and
the cluster size. As the sample size gets smaller, we found that the coverage probabilities
of the cluster level association and the cluster level variance component were lower. We
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also changed the values of the association of the joint model, setting γ1 = γ2 = 1.5. These
results had lower lower coverage probabilities for the cluster level variance component than
the cases where γ1 = γ2 = 1.
Table 4: Simulation Results for case IV : γ = (γ1, γ2, γ3)
T = (1, 1, 0.5)T
Our model Reduced model A Reduced model B
Parameter Est SE CP Percent Est SE CP Percent Est SE CP Percent
β0 = −1 -0.997 0.166 94.00 -0.997 0.166 94.00 -0.996 0.169 94.89
β1 = −0.5 -0.493 0.128 94.33 -0.493 0.128 94.50 -0.495 0.131 94.53
β2 = 0.2 0.199 0.034 94.50 0.199 0.034 94.50 0.199 0.034 94.89
α0 = 1.5 1.631 0.278 93.50 1.289 0.205 78.83 1.267 0.204 75.84
α1 = −1 -1.085 0.276 92.33 -0.859 0.213 86.83 -0.848 0.222 85.36
γ1 = 1 1.060 0.168 93.67 0.922 0.124 83.83
γ2 = 1 1.119 0.272 97.00 1.026 0.174 94.18
γ3 = 0.5 0.532 0.198 92.83 0.415 0.165 89.42
σa = 1 0.984 0.114 92.00 0.991 0.113 92.33 0.803 0.109 52.38
σb1 = 1 0.989 0.066 93.83 0.986 0.066 93.83 1.037 0.070 92.42
σb2 = 0.7 0.705 0.025 92.50 0.704 0.024 92.83 0.705 0.025 92.42
σe = 1 0.999 0.018 92.17 1.000 0.018 92.00 1.000 0.018 92.42
From the simulation study we presented, the estimates are sensitive to the violation
of the assumptions of the dependence structure between the longitudinal outcome and the
binary outcome. The results show that the binary part and the variance component have
poor coverage probability and biased estimates if we ignore the correct assumptions.
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2.4 APPLICATION
The HEMO study was a randomized controlled trial designed to identify the effects of dial-
ysis dose and membrane flux on morbidity and mortality for patients undergoing chronic
hemodialysis. The study enrolled 1846 patients nested within 75 units within 15 centers,
randomized by dose (standard or high) and by membrane type (high or low). One question
of secondary interest is the relationship between mid-arm muscle circumference and overall
health. To address this we fit a joint model with the logistic outcome being mortality and
the longitudinal component being mid-arm muscle circumference. A mixed model was fit to
the data with the longitudinal measure of mid-arm muscle circumference (MAMC) as the
outcome [33]. This measure was calculated using the following equation:
MAMC (cm) = mid-arm circumference (cm)
- 3.142 × triceps skinfold (TSF) (cm).
Our analysis included 1799 patients who had at least one measure of mid-arm muscle
circumference (MAMC). Time is calculated from randomization date to the visit date for
evaluation in years. The average number of follow-up visits is 3 (range 1-8) and the average
follow-up time is 2.09 years (range: 0 - 6.36). Out of 1799 patients, 840 (46.7%) died during
the study. The mean MAMC value is 24.6 (range 8.5 - 51.2).
The following baseline variables were included in both models: age at the first visit (mean
58 years), gender (44 % male), Index of Coexisting Disease (ICED) severity score which was
calculated with diabetes excluded (36 % with a score of 1, 31 % with a score of 2 and 33 %
with a score of 3), diabetic status (44 % diabetes) and race (63 % black). Also, the variables
indicating treatment assignment, dose (standard vs. high dose) and membrane type (high
or low flux membranes), were considered. Time in years since randomization date was also
included in the longitudinal model.
Since patients receive similar treatment if they are in the same unit, there will be a
within-cluster correlation for patients who are treated in the same unit (level 1). Also, the
repeated measurements of mid-arm muscle circumference (MAMC) (level 3) are nested within
a patient (level 2). We assumed that mortality might depend on the repeated measures
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of MAMC at both the unit level and the subject level. First, we built the longitudinal
submodel with the outcome of MAMC and then we built the logistic regression submodel
with the outcome of all-cause mortality. We linked the two sub-models using both subject
and cluster level random effects. The results, shown in Table 5, are based on 50 quadrature
points.
There was a significant linear decreasing pattern in MAMC over time. It decreased by
0.122 per year with a p-value of <0.001. Patients who had a higher index of coexistent
diseases (ICED) score had significantly higher mortality. Also, patients who had diabetes
had higher mortality when compared to the patients with no diabetes by 0.317 and a p-value
of 0.012. We observed that patients with an older age had a higher mortality by 0.052 with
a p-value of <0.001.
We found that the random effects at both the cluster and the subject levels were signif-
icant for MAMC. The estimate of σa (cluster level) was 0.420 with a p-value of 0.05 and σb
(subject level) was 3.179 with a p-value <0.001. The longitudinal MAMC was negatively
correlated with mortality rate at the subject level (γ2), but not at the unit level (γ1).
We also wanted to compare our proposed model with four reduced models. Two of these
reduced models include both the cluster level and the subject level of random effects in the
mixed model. Reduced model A was only linked via the cluster level. For this model, we
found that γ1 was slightly smaller in magnitude when compared to the full model but it was
still not significant. Reduced model B was only linked via the subject level and we found
that γ2 was very similar to our model. Since γ1 was not significant, the reduced model B was
also appropriate for our data. In both cases, while coefficients differed in magnitude across
the models, the overall inference is the same.
We also considered reduced models that contain only one random effect. These models,
C and D, are also included in the table. Reduced model C was only linked via the cluster
level. The model is as follows,
yijk = Z
T
ijkβ + ai + eijk
logit(pij) = Wijα + γ1ai.
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Reduced model D was only linked via the subject level, i.e.
yijk = Z
T
ijkβ + bij + eijk
logit(pij) = Wijα + γ2bij.
We found that the variance components, σa and σe, in reduced model C, and σb in
reduced model D were inflated. Also, there were some differences in estimates between the
two types of reduced models. For example, black patients have lower MAMC for models C
and D which contained only one random effect. Reduced model C also had a lower MAMC
time slope in magnitude when compared to the other models presented. These discrepancies
showed that the correct modeling at the cluster level or the subject level is important. We
also fitted models with the center level as a cluster level. Using unit level as a cluster level
had a higher association even though the cluster level was not significant. We tried to fit a
random slope in the time trend of MAMC, but it was not significantly different from zero.
For the goodness of fit test of the joint models, the performance of the proposed model
was investigated further by computing the Akaike Information Criterion (AIC) and Bayesian
Information Criterion (BIC). The AIC and the BIC were applied to the HEMO data, which
are shown in Table 5. The results show that our proposed model is better in terms of
goodness of fit when compared with other reduced models.
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Table 5: Results for HEMO data
Our model Red. model A Red. model B Red. model C Red. model D
Parameter Est SE P Est SE P Est SE P Est SE P Est SE P
MAMC
Intercept 23.844 0.523 0.000 23.814 0.518 0.000 23.767 0.525 0.000 23.762 0.494 0.000 23.871 0.540 0.000
Male 1.443 0.165 0.000 1.448 0.165 0.000 1.417 0.159 0.000 1.476 0.191 0.000 1.435 0.163 0.000
Back 0.803 0.196 0.000 0.810 0.195 0.000 0.805 0.199 0.000 0.740 0.204 0.001 0.789 0.212 0.001
High Kt/V 0.025 0.153 0.873 0.027 0.154 0.861 0.011 0.152 0.940 -0.067 0.162 0.681 0.004 0.151 0.980
High flux 0.130 0.129 0.318 0.130 0.129 0.316 0.121 0.127 0.343 0.113 0.133 0.401 0.118 0.129 0.367
ICED=3 -0.840 0.189 0.000 -0.838 0.189 0.000 -0.830 0.192 0.000 -0.744 0.211 0.001 -0.827 0.186 0.000
ICED=2 -0.413 0.205 0.049 -0.411 0.205 0.050 -0.397 0.201 0.054 -0.425 0.189 0.028 -0.407 0.203 0.050
Diabetes 0.907 0.210 0.000 0.904 0.211 0.000 0.907 0.209 0.000 0.862 0.207 0.000 0.922 0.217 0.000
Age -0.002 0.008 0.789 -0.002 0.007 0.840 -0.002 0.007 0.838 -0.002 0.007 0.817 -0.003 0.007 0.635
Time -0.122 0.031 0.000 -0.115 0.031 0.001 -0.123 0.031 0.000 -0.014 0.031 0.650 -0.123 0.031 0.000
Logit
Intercept -4.001 0.314 0.000 -3.923 0.303 0.000 -3.859 0.324 0.000 -3.801 0.314 0.000 -3.879 0.324 0.000
Male 0.230 0.136 0.096 0.238 0.128 0.070 0.232 0.122 0.064 0.241 0.119 0.047 0.233 0.123 0.064
Back -0.144 0.152 0.350 -0.142 0.148 0.345 -0.117 0.142 0.411 -0.106 0.138 0.444 -0.118 0.143 0.410
High Kt/V -0.001 0.103 0.994 0.003 0.101 0.976 0.031 0.104 0.776 0.025 0.101 0.808 0.030 0.104 0.772
High flux -0.074 0.094 0.435 -0.072 0.089 0.423 -0.055 0.087 0.532 -0.060 0.084 0.481 -0.055 0.088 0.535
ICED=3 1.173 0.153 0.000 1.134 0.151 0.000 1.102 0.144 0.000 1.088 0.142 0.000 1.109 0.143 0.000
ICED=2 0.717 0.175 0.000 0.696 0.167 0.000 0.679 0.167 0.000 0.664 0.161 0.000 0.682 0.168 0.000
Diabetes 0.317 0.122 0.012 0.303 0.118 0.013 0.282 0.119 0.022 0.282 0.117 0.020 0.284 0.120 0.022
Age 0.052 0.005 0.000 0.051 0.005 0.000 0.051 0.005 0.000 0.050 0.005 0.000 0.051 0.005 0.000
γ1 -1.178 1.125 0.300 -1.094 0.685 0.116 -0.209 0.193 0.285
γ2 -0.120 0.020 0.000 -0.124 0.019 0.000 -0.124 0.019 0.000
Var. Comp.
σa 0.420 0.214 0.050 0.432 0.144 0.004 0.558 0.110 0.000 0.804 0.072 0.000
σb 3.179 0.096 0.000 3.174 0.094 0.000 3.151 0.094 0.000 3.200 0.093 0.000
σe 1.832 0.115 0.000 1.832 0.115 0.000 1.832 0.115 0.000 3.500 0.096 0.000 1.832 0.115 0.000
AIC 27811.9 27850.8 27828.1 31038.4 27839.0
BIC 27943.8 27977.2 27954.5 31159.3 27959.9
24
2.5 DISCUSSION
Hierarchical structure is common in many biomedical studies, and ignoring the multi-level
correlation dependence will lead to incorrect results. In this paper we developed a multi-
level joint model of a longitudinal and a binary outcome. The two sub-models were linked
with both the cluster and the subject level random effects. The results were compared with
models that assumed only one level of dependence. The Gaussian quadrature technique
was implemented using the aML software. Our simulation results showed that ignoring the
correlations between outcomes can cause biased estimates.
In our motivating example of the HEMO study, the association between the repeated
measurement of MAMC and the mortality rate were significant, but not for the association
between unit level and mortality rate. In this example, the reduced model A was not appro-
priate because the model was linked only with the cluster level. Although the association
of the cluster level was not significant in the HEMO study, it is still important to check
for associations. We fitted the model with the center level as a cluster level. Using unit
level as a cluster level had higher association even though it was not significant. We also
tried to fit both a random intercept and a random slope in the time trend of MAMC, but
random slope was not significantly different from zero. Our model assumed the cluster level
random effect and subject level random effect were independent. For further investigation,
the generalization of them could be considered.
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3.0 INDIVIDUAL PREDICTIONS OF JOINT MODEL
3.1 INTRODUCTION
In joint modeling studies, investigators often want to predict an individual mortality rate
in situations where future individualized treatments may be considered. There are some
papers which present the subject-specific predictions in the joint modeling of longitudinal and
survival outcomes. Taylor et al. [34] and Yu et al. [35] focused on individualized predictions
for disease progression. They predicted future prostate-specific antigen (PSA) biomarkers
and the predicted probability of cancer recurrence for censored and alive patients. The
Markov chain Monte Carlo (MCMC) method has been applied to have individual draws.
Garre et al. [36] proposed a joint latent class model for longitudinal and survival data with
two latent classes and their predictions were better than other joint models. Proust-Lima
and Taylor [37] focused on the dynamic prognostic tool from a joint latent class model and
evaluated the predictive accuracy measures. Rizopoulos [38] assessed the predictive ability
of the longitudinal marker of the joint model. Also, Horrocks et al. [27] considered the
prediction of pregnancy in the joint model of longitudinal and binary outcomes.
In this chapter, we will fit our proposed model in WinBUGS, which is for Bayesian
analysis using Markov chain Monte Carlo (MCMC) methods. Guo and Carlin [13] devel-
oped the method of Henderson into a fully Bayesian version using the Markov chain Monte
Carlo technique. We will compare the estimates from using the Gaussian quadrature tech-
nique implemented in aML with the fully Bayesian approach via Markov Chain Monte Carlo
(MCMC) methods.
Next, we focus on individualized predictions of mortality for a patient. The motivation
for this work arose from individual prediction of our proposed model. Here, the longitudinal
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measures of mid-arm muscle circumference (MAMC) serve as an indicator of health. By
observing the longitudinal MAMC, we will be able to calculate the predicted probability of
individual mortality.
3.2 METHODS
Let Yijk denote the k-th repeated measure for the j-th subject within the i-th cluster (i =
1, 2, ..., n, j = 1, 2, ..., ni, and k = 1, 2, ...,mij). Let pij denote the probability of response
for the j-th subject of a binary zero-one outcome variable, Xij. Let Zijk and Wij denote
the covariate vectors of fixed effects for the longitudinal outcome model and the logistic
regression model, respectively. In this model, ai and bij denote the random effects at the
cluster and subject levels, respectively. They are assumed to be independent and identically
distributed according to a normal distribution with mean 0 and corresponding variances, e.g.
σ2a and σ
2
b .
We define the joint model as
yijk = Z
T
ijkβ + ai + bij + eijk
logit(pij) = Wijα + γ1ai + γ2bij,
(3.1)
where β and α are unknown vectors of parameters. In this model γ1 and γ2 represent the
association between the two models at each cluster and subject level. The error term, eijk is
assumed to be N(0, σ2e) and independent of (ai, bij, Xij). Let Oij denote the observed data
for the i-th subject within the j-th cluster.
The individual patient has a different predicted probability, standard error and confidence
bands using the Bayesian posterior distribution. The predicted probability of death for a
subject is
Pˆij =
exp(Wijαˆ + γˆ1aˆi + γˆ2bˆij)
1 + exp(Wijαˆ + γˆ1aˆi + γˆ2bˆij)
, (3.2)
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where αˆ is the estimated coefficient of the logistic regression submodel, and γˆ1and γˆ2 are
the estimated associations of the joint model at the cluster level and the subject level,
respectively. The predicted subject level and cluster level random intercepts are aˆi and bˆij,
respectively.
We will fit our proposed model in WinBUGS 1.4.3 which is based on the Markov Chain
Monte Carlo (MCMC) method. It can be called from R using the R package ‘R2WinBUGS’.
WinBUGS has several advantages when fitting Bayesian models providing great flexibility,
especially for multilevel modelling. There is also no restriction on number of levels of ran-
dom effects. On the other hand, the program uses more computational time than a standard
joint model fit using PROC NLMIXED in SAS. While this is not necessarily a fair com-
parison, since more complex models can not be fit using NLMIXED in SAS, it is certainly
a consideration. Part of this computational burden arises from the fact that the estimates
are simulated from posterior distributions. We used the estimates from the likelihood based
method using the Gaussian quadrature techniques for the initial values of the parameters
for the WinBUGs program to make the simulation computationally efficient.
Following the approach used by Guo and Carlin [13], we used proper but vague prior dis-
tributions, so that the priors will have minimal impact relative to data. For the longitudinal
submodel, we assumed multivariate normal and inverse gamma priors for the main effects
and the error variance, respectively. For the logistic regression submodel, normal priors were
used. For the cluster level and the subject level random effects, the normal priors were used.
Again, the normal priors were used for the associations of the joint model. To determine the
accuracy of the predicted values, we computed ROC curves.
3.3 SIMULATION STUDY
We conducted a simulation study to better understand the performance of the proposed
model when it is fit in the BUGS (Bayesian inference Using Gibbs Sampling) software using
Markov chain Monte Carlo (MCMC) methods. The development of the BUGS project is
currently focused on OpenBUGS, while WinBUGS is stable and not undergoing further
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development. BRugs is an R package, that allows OpenBUGS to interface with R. Here, we
used OpenBUGS 3.2.2 for the simulation study.
For all simulations we simulated data on 500 subjects with a cluster size of 50, so that
there were 10 subjects within each of the clusters. The results presented are based on 600
simulated samples for each scenario. The model below was used for generating data:
yijk = β0 + β1Zij + β2time+ ai + bij + eijk
logit(pij) = α0 + α1Zij + γ1ai + γ2bij.
Let yijk represent the repeated measurement at the integer time k, with k ranging from 1
to 5. We generated the subject-level covariate, Zij, from a binary distribution with probabil-
ity 0.5. The coefficient parameters were as follows; β = (β0, β1, β2)
T = (−1,−.5,−.2)T . The
random intercepts ai and bij were also included in the model. We assumed ai
iid∼ N(0, σ2a)
with σ2a = 1 and bij
iid∼ N(0, σ2b ) with σ2b = 1. Since the repeated measures from a subject
j share the common random effects bij and the subjects from a cluster share the common
random effects ai, the correlation is induced from the random effects. Here, the covariance
structure is compound symmetry where the variance at all time points is the same and the
correlation between any two distinct measurements is the same.
The error term was eijk
iid∼ N(0, σ2e) with σ2e = 1. The logistic regression model included an
intercept α0 and the subject-level covariate Zij with coefficient α = (α0, α1)
T = (1.5,−1)T .
Also, the random effects ai, at the cluster level, and bij, at the subject level, were included
in the model. We assumed that the coefficient parameters were as follows; γ = (γ1, γ2)
T =
(1, 1)T . We used two MCMC sampling chains of 10,000 iterations each, following a 5,000-
iteration burn-in period.
Table 6 presents the simulation results. The estimates of our proposed model have
very small bias and the coverage probability shows that the performance of our model is
reasonable using a Bayesian approach. Figure 1 presents boxplots of simulation results with
600 samples providing graphs of the distribution of the estimates. The estimates of both the
longitudinal model margin and the logistic regression model margin are unbiased, but the
variance component of cluster level, σa, is highly variable with some outliers when compared
to the other σ’s. Also, the association parameters of the two models, γ1 and γ2, appear to
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have larger variability than the other parameters. The area under the curve (AUC), which
estimates the prediction performance, is 0.8326 using the average of 600 samples of the data.
For the simulation study we presented, we also note that the estimates using MCMC
methods were unbiased with reasonable coverage probabilities. Based on the AUC results,
the proposed model does a good job for prediction of binary outcome.
Table 6: Simulation Results
Parameter Est SD CP Percent
β0 = −1 -0.997 0.163 93.8
β1 = −0.5 -0.507 0.103 94.3
β2 = 0.2 0.199 0.014 96.5
α0 = 1.5 1.526 0.251 94.3
α1 = −1 -1.010 0.257 93.3
γ1 = 1 1.037 0.152 95.5
γ2 = 1 1.041 0.164 94.3
σa = 1 0.995 0.242 95.0
σb = 1 1.007 0.082 94.8
σe = 1 1.000 0.032 95.5
CP is the coverage probability of the 95 percent credible interval.
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Figure 1: Boxplots of simulation results
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3.4 APPLICATION
The HEMO study was a randomized controlled trial designed to identify the effects of dial-
ysis dose and membrane flux on morbidity and mortality for patients undergoing chronic
hemodialysis. The study enrolled 1846 patients nested within 75 units within 15 centers,
randomized by dose (standard or high) and by membrane type (high or low). One question
of secondary interest is the relationship between mid-arm muscle circumference and overall
health. To address this we fit a joint model with the logistic outcome being mortality and
the longitudinal component being mid-arm muscle circumference. A mixed model was fit to
the data with the longitudinal measure of mid-arm muscle circumference (MAMC) as the
outcome [33]. This measure was calculated using the following equation:
MAMC (cm) = mid-arm circumference (cm)
- 3.142 × triceps skinfold (TSF) (cm).
Our analysis included 1799 patients who had at least one measure of mid-arm muscle circum-
ference (MAMC). Time is calculated from randomization date to the visit date for evaluation
in years. The average number of follow-up visits is 3 (range 1-8) and the average follow-up
time is 2.09 years (range: 0 - 6.36). Out of 1799 patients, 840 (46.7%) died during the study.
The mean MAMC value is 24.6 (range 8.5 - 51.2).
The following baseline variables were included in both models: age at the first visit (mean
58 years), gender (44 % male), Index of Coexisting Disease (ICED) severity score which was
calculated with diabetes excluded (36 % with a score of 1, 31 % with a score of 2 and 33 %
with a score of 3), diabetic status (44 % diabetes) and race (63 % black). Also, the variables
indicating treatment assignment, dose (standard vs. high dose) and membrane type (high
or low flux membranes), were considered. Time in years since randomization date was also
included in the longitudinal model.
Since patients receive similar treatment if they are in the same unit, there will be a
within-cluster correlation for patients who are treated in the same unit (level 1). Also, the
patients are nested within hospital (level 2) and finally the repeated measurements of mid-
arm muscle circumference (MAMC) are nested within a patient (level 3). We assumed that
32
mortality might depend on the repeated measures of MAMC at both the unit level and the
subject level. First, we built the longitudinal submodel with the outcome of MAMC and
then we built the logistic regression submodel with the outcome of all-cause mortality. We
linked the two sub-models using both subject and cluster level random effects. The results,
shown in the right hand column of Table 7, are based on two MCMC sampling chains of
20,000 iterations each, following a 10,000-iteration burn-in period. The left hand column of
Table 7 contains the results obtained from using gaussian quadrature techniques based on
50 quadrature points.
Most of the estimates are similar when comparing the gaussian quadrature techniques
with the MCMC method. If we look at the results from the analysis based on the MCMC
method, there was a significant linear decreasing pattern in MAMC over time. It decreased
by 0.122 per year, since the 95% credible interval does not include 0. Patients who had a
higher index of coexistent diseases (ICED) score had significantly higher mortality. Also,
patients who had diabetes had higher mortality when compared to the patients with no
diabetes by 0.320. We observed that patients with an older age had a higher mortality by
0.052.
We found that the random effects at both the cluster and the subject levels were signifi-
cant for MAMC. The estimate of σa (cluster level) was 0.355 and σb (subject level) was 3.198.
The longitudinal MAMC was negatively correlated with mortality rate at the subject level
(γ2) and at the unit level (γ1). The association at the cluster level, γ1, was not significant
in the gaussian quadrature method. This is the only difference when we compare with the
results from the two methods.
Figure 2 shows the individual trajectory of the MAMC for two selected patients, A and
B, who are both alive. Patient A is 38 years old, black, male with an ICED score of 2 and no
diabetes. Patient B is 68 years old, non black, male with an ICED score of 3 with diabetes.
In this figure we see a clear difference in the trajectories of these 2 subjects. Patient A
exhibited a rather stable pattern over time. The predicted probability of death is 0.2078
with a credible interval of (0.1247, 0.3117). Patient B, on the other hand, has a trajectory
with a decreasing pattern at the end of measurement times. The predicted probability of
death for this patient is 0.8405 with a credible interval of (0.7576, 0.9050). Note that patient
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B has a much higher probability of death when compared with patient A. Figure 3 shows the
ROC curve for the HEMO data. The area under the curve (AUC), estimates the prediction
performance which is 0.7869 in our proposed model. Based on this result, the proposed
model does a good job of predicting death in this cohort.
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Table 7: Results for HEMO data: Gaussian Quadrature vs. MCMC
Gaussian Quadrature MCMC
Parameter Est. P-value Posterior Mean 95% CI
MAMC
Intercept 23.844 0.000 23.800 (23.010, 24.610)
Male 1.443 0.000 1.454 (1.117, 1.774)
Back 0.803 0.000 0.814 (0.472, 1.160)
High Kt/V 0.025 0.873 0.033 (-0.277, 0.343)
High flux 0.130 0.318 0.136 (-0.173, 0.445)
ICED=3 -0.840 0.000 -0.828 (-1.229, -0.425)
ICED=2 -0.413 0.049 -0.406 (-0.809, 0.001)
Diabetes 0.907 0.000 0.913 (0.577, 1.246)
Age -0.002 0.789 -0.002 (-0.014, 0.009)
Time -0.122 0.000 -0.122 (-0.160, -0.085)
Logit
Intercept -4.001 0.000 -4.047 (-4.741, -3.436)
Male 0.230 0.096 0.229 (0.001, 0.461)
Back -0.144 0.350 -0.150 (-0.412, 0.101)
High Kt/V -0.001 0.994 -0.007 (-0.225, 0.208)
High flux -0.074 0.435 -0.076 (-0.297, 0.137)
ICED=3 1.173 0.000 1.186 (0.910, 1.470)
ICED=2 0.717 0.000 0.728 (0.457, 1.003)
Diabetes 0.317 0.012 0.320 (0.094, 0.549)
Age 0.052 0.000 0.052 (0.044, 0.062)
γ1 -1.178 0.300 -1.910 (-3.773, -0.759)
γ2 -0.120 0.000 -0.120 (-0.159, -0.082)
Var. Comp.
σa 0.420 0.050 0.355 (0.177, 0.572)
σb 3.179 0.000 3.198 (3.074, 3.324)
σe 1.832 0.000 1.832 (1.790, 1.875)
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Figure 2: Observed MAMC for Patients A and B
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Figure 3: ROC Curve for HEMO data
3.5 DISCUSSION
The individualized predictions based on joint models are of increasing interest to many scien-
tific investigators and the methods presented here provide an approach to address prediction.
We focused on individual predictions estimated from the joint model of longitudinal and bi-
nary outcomes using the Bayesian approach available in the software package WinBUGS.
This approach relies on Markov Chain Monte Carlo (MCMC) methods for the joint model
analysis. WinBUGS provides great flexibility and there is no restriction on the number of
random effects that can be included in the model. It can also fit more complex models, such
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as multilevel models. We used proper but vague prior distributions in WinBUGS, so that
the priors will have minimal impact relative to the data.
We focused on the individual predictions of our proposed model of multilevel joint model
of longitudinal and binary outcomes. The individual prediction of mortality can be calculated
from the draws in the Markov chain. We applied this method to the HEMO data to assess the
relationship between the longitudinal trajectory of mid-arm muscle circumference (MAMC)
and the predicted mortality. We observed a steep decreasing pattern of MAMC which may
be an indicator of an increased mortality rate and suggest directions for the future treatment.
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4.0 DISCUSSION
Hierarchical structure is common in many biomedical studies, such as longitudinal measures
nested within subject and then nested within hospital. If we ignore the multi-level correlation
dependence, it will lead to incorrect results. Here, we proposed a multi-level joint model of
a longitudinal and a binary outcome. The two sub-models were linked with both the cluster
and the subject level random effects. The results were compared with models that assumed
only one level of dependence. The Gaussian quadrature technique was implemented using
the aML software. The simulation study presented showed that the estimates were sensitive
to the violation of the assumptions of the dependence structure between the longitudinal
outcome and the binary outcome. We applied our model to the HEMO data which was a
randomized controlled trial designed to identify the effects of dialysis dose and membrane flux
on morbidity and mortality for patients undergoing chronic hemodialysis. The patients are
nested within a unit and finally the repeated measurements of mid-arm muscle circumference
(MAMC) are nested within a patient.
We also extended our approach to obtain individual predictions based on the proposed
joint model. The motivation for this work arose from individual prediction of our proposed
model. We fit our proposed model in software package (WinBUGS) for Bayesian analysis us-
ing Markov chain Monte Carlo (MCMC) methods. We focused on the individual predictions
of our proposed model of the multilevel joint model of longitudinal and binary outcomes.
The simulation study presented showed that based on the area under the curve (AUC) re-
sults, the proposed model is able to predict well for the binary outcome. The area under the
curve (AUC) for the HEMO data also indicate that the model does a good job of predicting
death in this cohort. Thus, the proposed method provides a mechanism for understanding
the relationship between a longitudinal measure and a given binary outcome.
39
WinBUGS provides great flexibility and there is no restriction on the number of random
effects that can be included in the model. It can also fit more complex models, such as
multilevel models. On the other hand, the program uses more computational time than a
standard joint model fit using PROC NLMIXED in SAS. While this is not necessarily a
fair comparison, since more complex models can not be fit using NLMIXED in SAS, it is
certainly a consideration.
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